Vice-President, Commercialization
CurrentBusiness Development and Commercialization lead for a pre-clinical CRISPR based gene therapy company focused on a range of mental illnesses including chronic anxiety, major depressive disorders and Alzheimer's disease. Company is developing both a platform and a therapeutic.